EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association of Ocular Surface Immune Cells With Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study

Eric J Kuklinski, Yinxi Yu, Gui-Shuang Ying, Penny A Asbell, DREAM Study Research Group

Investigative Opthalmology & Visual Science · 2023

DOI: 10.1167/iovs.64.12.7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Opthalmology & Visual Science, 2023. Verfasst von Eric J Kuklinski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers New Jersey Medical School, Newark, New Jersey, United States. Hauptthemen laut MEDLINE: Dry Eye Syndromes, Sjogren's Syndrome. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Dry eye disease (DED) is a multifactorial, heterogeneous disease of the ocular surface with one etiology being ocular surface inflammation. Studies using animal models demonstrate the role of ocular surface immune cells in the inflammatory pathway leading to DED, but few have evaluated humans. This study described the white blood cell population from the ocular surface of patients with DED and assessed its association with DED signs and symptoms in participants of the Dry Eye Assessment and Management (DREAM) study.

Methods

Participants were assessed for symptoms using the Ocular Surface Disease Index, signs via corneal staining, conjunctival staining, tear break-up time, and Schirmer test, and Sjögren's syndrome (SS) based on the 2012 American College of Rheumatology classification criteria. Impression cytology of conjunctival cells from each eye was evaluated using flow cytometry: T cells, helper T cells (Th), regulatory T cells (Tregs), cytotoxic T cells, and dendritic cells.

Results

We assessed 1049 eyes from 527 participants. White blood cell subtype percentages varied widely across participants. Significant positive associations were found for Th and conjunctival staining (mean score of 2.8 for 0% Th and 3.1 for >4.0% Th; P = 0.007), and corneal staining (mean score of 3.5 for 0% Th and 4.3 for >4.0% Th; P = 0.01). SS was associated with higher percent of Tregs (median 0.1 vs. 0.0; P = 0.01).

Conclusions

Th were associated with more severe conjunctival and corneal staining, possibly indicating their role in inflammation leading to damage of the ocular surface. There is no consistent conclusion about Tregs in SS, but these results support that Tregs are elevated in SS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dry Eye SyndromesSjogren's SyndromeAnimalsHumansConjunctivaLeukocytesInflammation

Autor:innen und Institutionen

  • Rutgers New Jersey Medical School, Newark, New Jersey, United States.
  • Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pennsylvania, United States.
  • University of Memphis, Memphis, Tennessee, United States.

Förderung

  • NEI NIH HHS

Zitieren

APA

Kuklinski, E. J., Yu, Y., Ying, G. S., Asbell, P. A., & DREAM Study Research Group (2023). Association of Ocular Surface Immune Cells With Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.64.12.7

Vancouver

Kuklinski EJ, Yu Y, Ying GS, Asbell PA, DREAM Study Research Group. Association of Ocular Surface Immune Cells With Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study. Investigative Opthalmology & Visual Science. 2023. doi:10.1167/iovs.64.12.7

BibTeX
@article{Kuklinski2023,
  author = {Kuklinski, Eric J and Yu, Yinxi and Ying, Gui-Shuang and Asbell, Penny A and DREAM Study Research Group, DREAM Study Research Group},
  title = {Association of Ocular Surface Immune Cells With Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study},
  journal = {Investigative Opthalmology & Visual Science},
  year = {2023},
  doi = {10.1167/iovs.64.12.7}
}
Kostenlos starten →